|
|
 |
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
 |
Pharmaceutical Nanotechnology: Applications & Commercialisation (2011)
|
|
|
|
 |
|
Click here for information on our co-located conference: RNAi, miRNA, and siRNA, taking place on the 27th-28th June 2011
|
View the Programme | Register Your Place | Request Sponsorship Information
|
SMi Presents...
Pharmaceutical Nanotechnology: Applications & Commercialisation
About the conference
SMi are proud to present Pharmaceutical Nanotechnology: Applications & Commercialisation, taking place in London on June 29th and 30th, 2011.
Nanotechnology is a multidisciplinary scientific field that is currently undergoing explosive development. Nano-enhanced medicines are opening new opportunities for therapeutic delivery and targeting, technology is also allowing agents that previously could not be used effectively as conventional formulations due to poor bioavailability or drug instability to advance into clinical development.
This case study driven conference will address not only the latest scientific developments, but also the know-how required to successfully translate these discoveries and technologies into a commercially successful product.
|
|
The conference will address:
Engineering, formulation & drug delivery: Comparing available technologies and selecting the best option for your project, advancements in miniaturisation and crossing the blood-brain-barrier using nanotechnologies
Nano-enabled nucleic acid therapeutic delivery: Oligonucleotide and siRNA therapeutic delivery
Translating discoveries into commercial successes: The business case for nanotechnology, improving translation of academic nanomedicine research and case studies covering the transition from academic work to industrial application
Regulatory considerations, IP issues & partnering opportunities: Regulatory challenges for nanomedicines and industry partnering opportunities, issues and solutions
Interested in speaking at the conference? Contact the Conference Producer.
For sponsorship and exhibition opportunities, Contact our Sponsorship Department.
|
 |
Make sure you save the date for our half day post-conference workshop
|
Associated with the conference there will be a half-day interactive workshop on "Nanomedicines: Regulatory Challenges and Opportunities", taking place on Friday 1st of July. This workshop will give participants an understanding nanopharmaceutical applications and regulatory considerations, including an overview of the technology, development considerations, manufacturing, safety and pricing/reimbursement issues.
Leading this workshop will be Brian Kelly, Regulatory Lawyer, Covington & Burling LLP and Simon Holland, Director, Process Understanding & Control, GlaxoSmithKline. To see more information about the workshop, please see the comprehensive workshop page
|
Workshop hosted by:
|
|
|
|
|
|
|
 |
|
|
|
|
 |
|
|
|
|
Pharmaceutical Nanotechnology: Applications & Commercialisation, Conference Documentation - PDF Documentation on CD ROM, Single User License
|
|
£499.00 |
 |
|
|
Pharmaceutical Nanotechnology: Applications & Commercialisation, Conference Documentation - Hard Copy Documentation, Single User License
|
|
£499.00 |
|
|
|
Pharmaceutical Nanotechnology: Applications & Commercialisation, Conference Documentation - PDF Documentation on CD ROM, Site License
|
|
£1,497.00 |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
Events Home Page
